{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:37:55Z","timestamp":1759451875986,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2018.05.065","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T17:44:42Z","timestamp":1527356682000},"page":"4736-4742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus"],"prefix":"10.1016","volume":"37","author":[{"given":"Byron E.E.","family":"Martina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Smreczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Orlowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Marzec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Trebas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouke M.","family":"Roose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Zmudzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Gerhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wohlsein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Baumg\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Koraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.065_b0005","doi-asserted-by":"crossref","unstructured":"Rabies vaccines: WHO position paper--recommendations. Vaccine. 2010;28(44):7140\u20132.","DOI":"10.1016\/j.vaccine.2010.08.082"},{"key":"10.1016\/j.vaccine.2018.05.065_b0010","first-page":"185","article-title":"Ability of rabies vaccine strains to elicit cross-neutralising antibodies","volume":"125","author":"Brookes","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"9951","key":"10.1016\/j.vaccine.2018.05.065_b0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"issue":"6703","key":"10.1016\/j.vaccine.2018.05.065_b0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.299.6703.830","article-title":"Failure of interferon alfa and tribavirin in rabies encephalitis","volume":"299","author":"Warrell","year":"1989","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.065_b0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/344905","article-title":"Management of rabies in humans","volume":"36","author":"Jackson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.065_b0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199807093390208","article-title":"Weekly clinicopathological exercises. Case 21\u20131998. A 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite","volume":"339","author":"Case records of the Massachusetts General Hospital","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.065_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/neup.12094","article-title":"Survival of rabid rabbits after intrathecal immunization","volume":"34","author":"Kesdangsakonwut","year":"2014","journal-title":"Neuropathology"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.065_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2014.02.013","article-title":"Survival from rabies encephalitis","volume":"339","author":"de Souza","year":"2014","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.065_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13550280590900418","article-title":"The role of immune responses in the pathogenesis of rabies","volume":"11","author":"Hooper","year":"2005","journal-title":"Journal Neurovirology"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.065_b0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.15-0361","article-title":"Profile of cytokines and chemokines triggered by wild-type strains of rabies virus in mice","volume":"94","author":"Appolinario","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.065_b0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1292\/jvms.54.409","article-title":"Immunohistochemical and histopathological study of experimental rabies infection in mice","volume":"54","author":"Sinchaisri","year":"1992","journal-title":"J Veterinary Med Sci\/Japanese Soc Veterinary Sci"},{"issue":"19","key":"10.1016\/j.vaccine.2018.05.065_b0060","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1128\/JVI.79.19.12554-12565.2005","article-title":"Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virology"},{"key":"10.1016\/j.vaccine.2018.05.065_b0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fmicb.2018.00397","article-title":"Analysis of mouse brain transcriptome after experimental duvenhage virus infection shows activation of innate immune response and pyroptotic cell death pathway","volume":"9","author":"Koraka","year":"2018","journal-title":"Front Microbiol"},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.065_b0070","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/j.vaccine.2017.10.098","article-title":"The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model","volume":"37","author":"Smreczak","year":"2019","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.065_b0075","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2018.04.003","article-title":"The effect of combined drugs therapy on the course of clinical rabies infection in a murine model","volume":"37","author":"Smreczak","year":"2019","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.065_b0080","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.vaccine.2018.04.002","article-title":"Inhibition of caspase-1 prolongs survival of mice infected with rabies virus","volume":"37","author":"Koraka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.065_b0085","article-title":"Beitrag zur behandlung kollektiver Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch exp Pharmkol."},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.065_b0090","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1016\/j.vaccine.2017.10.109","article-title":"Re-evaluating the effect of Favipiravir treatment on rabies virus infection","volume":"37","author":"Banyard","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.05.065_b0095","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JCM.43.6.2786-2792.2005","article-title":"Development of a real-time, TaqMan reverse transcription-PCR assay for detection and differentiation of lyssavirus genotypes 1, 5, and 6","volume":"43","author":"Wakeley","year":"2005","journal-title":"J Clin Microbiol."},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.065_b0100","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2018.01.082","article-title":"Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication","volume":"37","author":"Marosi","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.065_b0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.2013.236","article-title":"Pyroptotic neuronal cell death mediated by the AIM2 inflammasome","volume":"34","author":"Adamczak","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.vaccine.2018.05.065_b0110","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1038\/cddis.2014.348","article-title":"Amyloid-beta induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease","volume":"5","author":"Tan","year":"2014","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.065_b0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Molecular cell."},{"issue":"12","key":"10.1016\/j.vaccine.2018.05.065_b0120","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1523\/JNEUROSCI.20-12-04398.2000","article-title":"Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines","volume":"20","author":"Rabuffetti","year":"2000","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.vaccine.2018.05.065_b0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/13550280009091951","article-title":"Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis","volume":"6","author":"Camelo","year":"2000","journal-title":"J Neurovirology"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.065_b0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2016.11.163","article-title":"Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor alpha-mediated neurotoxicity","volume":"482","author":"Ho","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.065_b0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12974-017-0853-2","article-title":"TNF-alpha promotes extracellular vesicle release in mouse astrocytes through glutaminase","volume":"14","author":"Wang","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.vaccine.2018.05.065_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2015.06.004","article-title":"Characterization of the lipopolysaccharide induced model of Parkinson's disease: role of oxidative stress and neuroinflammation","volume":"87","author":"Sharma","year":"2015","journal-title":"Neurochem Int"},{"key":"10.1016\/j.vaccine.2018.05.065_b0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fmicb.2016.00183","article-title":"The mitogen-activated protein kinase (MAPK) pathway: role in immune evasion by trypanosomatids","volume":"7","author":"Soares-Silva","year":"2016","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.065_b0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.05.065_b0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2004.04.034","article-title":"Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin","volume":"1014","author":"Brown","year":"2004","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.vaccine.2018.05.065_b0160","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.STR.29.12.2631","article-title":"Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells","volume":"29","author":"Malek","year":"1998","journal-title":"Stroke"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:29Z","timestamp":1759401209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":32,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X18307059"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}